Skip to content
Disclosery

Paradigm Biocapital Advisors LP: ORKA position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Paradigm Biocapital Advisors LP on ORKA, newest first. How the timeline and the estimate are built.

Paradigm Biocapital Advisors LP held 2,144,526 ORKA shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 2,144,526 shares
    Change vs previous 13F -175,790 shares

    3.82% of the 13F portfolio, value $204,094,539.

    13F-HR 0001855655-26-000014 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 2,320,316 shares
    Change vs previous 13F +610,000 shares

    2.33% of the 13F portfolio, value $113,811,500.

    13F-HR 0001855655-26-000011 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 1,710,316 shares
    Change vs previous 13F +1,710,316 shares

    1.39% of the 13F portfolio, value $51,839,678.

    13F-HR 0001855655-26-000003 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-03-31
    13F 0 shares
    Change vs previous 13F -819,660 shares

    13F-HR 0001855655-25-000007 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  5. period ended2024-12-31
    13F 819,660 shares
    Change vs previous 13F +100,000 shares

    0.55% of the 13F portfolio, value $15,893,207.

    13F-HR 0001855655-25-000004 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2024-09-30
    13F 719,660 shares
    Change vs previous 13F not available

    0.62% of the 13F portfolio, value $17,638,867.

    13F-HR 0001855655-24-000014 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).